who should not take retatrutide Gwyneth Paltrow, Andrew Huberman & Retatrutide UK Guide: Key Facts
Description
EClinicalMedicine , 2930
Yes-Zepbound and Mounjaro contain the same active ingredient (tirzepatide) but are FDA approved for different conditions: Zepbound for weight management and Mounjaro for type 2 diabetes
Broader immune-mediated reactions may develop weeks later or after dose escalation
The expanding role of GLP-1 medications beyond weight loss, such as their potential to treat conditions like sleep apnea or chronic heart failure, represents an exciting shift in healthcare
Now the question is, how do we create a more even playing field? Videos: Walter Zarnowitz UCSF Magazine Still curious?
